Market Overview The cancer gene therapy market is restoring as tumor suppressor gene replacement attempts to restore cellular defenses lost through mutation, offering rational approach for cancers with known suppressor inactivation like p53, RB, and PTEN. The Cancer Gene Therapy Market recognizes gene replacement as foundational strategy. Current Market Landscape p53 gene therapy most advanced....